Jeffrey A. Freeman

Partner

+1 404 653 6430 +1 404 653 6430
jeff.freeman@finnegan.com jeff.freeman@finnegan.com

271 17th Street, NW
Suite 1400
Atlanta, GA 30363-6209

vCard

Show Jeffrey's work in

Jeffrey Freeman enjoys a diverse practice focused on patent litigation, prosecution, and client counseling work, with particular expertise in Hatch-Waxman litigation. He has successfully represented clients in a broad range of technologies, including pharmaceuticals, chemicals, pulp and paper, plastics, oil and gas, cosmetics, inorganic materials, and food and beverage compositions.

Jeff’s litigation expertise includes U.S. district court litigation and appeals to the Federal Circuit, with extensive experience representing pharmaceutical patent holders in litigations arising under the Hatch-Waxman Act. He has argued multiple summary judgment motions, has served as trial counsel, has extensive brief writing and deposition experience, and has been involved in all aspects of litigation from fact and expert discovery, to claim construction, to settlement resolution.

Jeff’s prosecution practice focuses on portfolio development and value maximization. He has extensive experience drafting applications and managing patent family and world-wide prosecution portfolio strategies. Jeff has also successfully argued multiple appeals at the USPTO’s Patent Trial and Appeal Board (PTAB).

Jeff has a versatile counseling practice, aimed at providing clients with advice and analysis needed to make critical business decisions. His counseling expertise includes due diligence, landscape, freedom-to-operate, and patentability opinions, as well as advice concerning potential enforceability and remedies.

Jeff's pro bono work includes successful representation of veterans in disability benefits cases at the U.S. Court of Appeals, Veterans Claims.

Experience

Represented Pronova in Hatch-Waxman patent litigation concerning multiple ANDAs for generic versions of drug Lovaza®, resulting in judgment of patent infringement, validity, and enforceability in Pronova's favor.

1:09-cv-00286, 1:10-cv-00800, D. Del., Judges Farnan, Robinson, Thynge
12-1498, -1499, Fed. Cir., Judges Dyk, O'Malley, Wallach

Represented Otsuka Pharmaceuticals, Inc. in Hatch-Waxman litigations against seven companies seeking FDA approval to market generic copies of Abilify®, which had 2011 sales of over $5.2 billion. The district court found the asserted patent claims valid, enforceable and infringed in November 2010, and enjoined marketing of any generic until April 2015. The Federal Circuit affirmed that holding in May 2012, with Supreme Court Cert subsequently denied.

3:07-cv-01000, D.N.J., Judges Cooper, Goodman, Hughes
11-1126, -1127, Fed. Cir., Judges Lourie, Moore, Reyna

Represented Eli Lilly in Hatch-Waxman action against several defendants relating to Cialis®.

1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga

Counsel for Otsuka in Hatch-Waxman cases involving 24 companies seeking to market generic copies of Abilify^® following expiration of compound patent covering active ingredient in Abilify®. Only one case still pending following confidential resolutions of all other matters.

1:14-cv-01078, -04671, -02982, -07405, -05878, -06398 -08074 -03306, -06890, -05876, -08077, -03168, -07252, -07105 -05537, -03996, -06158, -04508, -04307, -06397, -07106, -01979, -03445; 1:15-cv-0161, -07584, -01585, -07803, -08830, -05109, -07802, -08955, -01716, -01967, -06353, -08305; 1:16-cv-05288, -05400, -05949, -07705 -02475, -02476, -08284, -05743, -00086, -08085, -00555, -00557, -07346, -06067, -00405, -00424, -05688, -09603; 1:17-cv-02754, -00392, D.N.J., Judges Simandle, Williams

Represented Huber in district court litigation concerning patents covering calcium carbonate supplement technology.

2:12-cv-05378, D.N.J., Judges Dickson, Hammer, Mannion, Salas, Waldor

Represented Georgia-Pacific in district court litigation concerning patents covering cellulose technology.

2:13-cv-00781, W.D. Wash., Judge Martinez

1 more

Insights

Conference

Corporate IP Institute 2019

October 29-30, 2019

Atlanta

Conference

Southeastern Regional Meeting of the American Chemical Society

October 31-November 3, 2018

Augusta

Seminar

Federal Circuit Mock Argument

September 18, 2014

Atlanta

Articles

The Continuing Importance of Written Opinions of Counsel Following the Supreme Court’s Decision in Octane Fitness and Highmark

July/August 2014

IP Litigator

Articles

District Court or the PTO: Choosing Where to Litigate Patent Invalidity

March/April 2014

IP Litigator

Seminar

Supreme Review: A Look at the High Court's IP Cases

March 25, 2014

Atlanta

3 more

News

Press Release

Finnegan Announces Seven New Partners

January 28, 2016

Press Release

Pronova Prevails in U.S. Lovaza® Patent Litigation

May 29, 2012

Professional Activities

American Bar Association
State Bar of Georgia
(Sections on Intellectual Property and Technology)

Admissions and Education

Admissions

Georgia

U.S. District Court, N.D. Georgia
U.S. Court of Appeals, Federal Circuit
U.S. Court of Appeals, Veterans Claims
U.S. Patent and Trademark Office

Education

University of Georgia School of Law: J.D., cum laude, 2005

Georgia Institute of Technology: B.S., Chemical Engineering, with honors, 2002

Jeffrey's Practices

Patent Litigation: Abbreviated New Drug Application (ANDA) Litigation; Appeals; Patent Trial
Patent Office Examinations: Appeals to the PTAB; Prosecution
Patent Portfolio Management, Monetization, and Transactions: Due Diligence; Opinions and Counseling; Portfolio Management

Jeffrey's Industries

Chemical
Clean Energy and Renewables
Consumer Products
Oil and Gas
Pharmaceutical
Textiles